ホーム › 慢性骨髄性白血病 › テキサス › Houston
Houston、TXにおける慢性骨髄性白血病の臨床試験
Houstonとその周辺地域（約30マイル以内）の拠点で、慢性骨髄性白血病に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- UT MD Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
被験者募集中観察研究
- Texas Children's Hospital, Houston
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
被験者募集中第2相
- MD Anderson Cancer Center, Houston
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
被験者募集中第2相
- The University of Texas M. D. Anderson Cancer Center, Houston
Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
被験者募集中第2相
- MD Anderson Cancer Center, Houston
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
被験者募集中第1相
- M D Anderson Cancer Center, Houston
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
被験者募集中第2相
- M D Anderson Cancer Center, Houston
Study of Olverembatinib (HQP1351) in Patients With CML-CP
被験者募集中第3相
- Ascentage Investigative Site #1501, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
Asciminib Roll-over Study
被験者募集中第4相
- Uni Of TX MD Anderson Cancer Cntr, Houston
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
被験者募集中第2相
- M D Anderson Cancer Center, Houston
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
被験者募集中観察研究
- University of Texas MD Anderson Cancer Center, Houston
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
被験者募集中第1相
- The University of Texas MD Anderson Cancer Center, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
被験者募集中第2相
- MD Anderson, Houston
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
被験者募集中第1相
- MD Anderson Cancer Center, Houston
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
被験者募集中第1/2相
- The University of Texas M.D. Anderson Cancer Center, Houston
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
被験者募集中第1相
- University of Texas MD Anderson Cancer Center, Houston
TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
被験者募集中第1相
- The University of Texas MD Anderson Cancer Center, Houston
他の都市における慢性骨髄性白血病の試験
- Seattle, WA11件の研究
- New York City, NY11件の研究
- Birmingham, AL6件の研究
- Detroit, MI6件の研究
- Chicago, IL6件の研究
- Portland, OR6件の研究
- Philadelphia, PA6件の研究
- Baldwin Park, CA6件の研究
- Nashville, TN5件の研究
- Columbus, OH5件の研究
- Boston, MA5件の研究
- Atlanta, GA5件の研究
Houstonにおける他の研究
- 非小細胞肺癌145件の研究
- 乳がん126件の研究
- がん（全種類）121件の研究
- 転移性癌104件の研究
- 大腸癌102件の研究
- 卵巣がん89件の研究
- 急性骨髄性白血病85件の研究
- 肺がん78件の研究
- 前立腺がん76件の研究
- 子宮内膜がん68件の研究
- 膵臓がん61件の研究
- 悪性黒色腫59件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。